Literature DB >> 27306884

Educational Intervention Improves Compliance With AAN Guidelines for Return Epilepsy Visits: A Quality Improvement Project.

Gary R Nelson1, Francis M Filloux2, Lynne M Kerr2.   

Abstract

In 2011, the American Academy of Neurology (AAN) released guidelines for return seizure visits detailing 8 points that should be addressed during such visits. These guidelines are designed to improve routine follow-up care for epilepsy patients. The authors performed a quality improvement project aimed at increasing compliance with these guidelines after educating providers about them. The authors performed a chart review before and after an intervention which included: education regarding the guidelines, providing materials to remind providers of the guidelines, and templates to facilitate compliance. The authors reviewed charts at 2 and 6 months after the intervention. Significant improvement in documentation of 4 of the 8 measures was observed after this educational intervention. This suggests that simple educational interventions may help providers change practice and can improve compliance with new guidelines while requiring minimal time and resources to implement.
© The Author(s) 2016.

Entities:  

Keywords:  education; epilepsy; quality improvement; safety; seizures

Mesh:

Year:  2016        PMID: 27306884     DOI: 10.1177/0883073816653200

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  Conceptualization and implementation of an interdisciplinary clinic for children with drug-resistant epilepsy during the COVID-19 pandemic.

Authors:  Debopam Samanta; Vimala Elumalai; Vidya C Desai; Megan Leigh Hoyt
Journal:  Epilepsy Behav       Date:  2021-10-29       Impact factor: 2.937

2.  Assessment of Parkinson disease quality measures on 12-month patient outcomes.

Authors:  Justin Martello; Lisa M Shulman; Erik Barr; Ann Gruber-Baldini; Melissa J Armstrong
Journal:  Neurol Clin Pract       Date:  2020-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.